Fintel reports that on February 7, 2025, B of A Securities initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a Buy recommendation. As of January 29, 2025, the average one-year price ...
The Bengaluru man shared a receipt from the fruit shop showing pomegranate labelled as "anaar".(X/sgowda) Surprised by the use of the word 'anaar' for pomegranate, the user took to social media to ...
Shares of Candel Therapeutics surged after its board chair picked up 1.25 million shares of the company. The stock gained 44% at $9.39 on Thursday. Shares are up over 760% for the past year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback